Gallstone. Gallstone ileus
Conditions
Interventions
Intervention 1: Control group: They received Ursodeoxycholic acid tablets as 300 mg daily. Intervention 2: Intervention group: They received Ursodeoxycholic acid 300 mg twice daily.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: All adult female individuals who have undergone sleeve gastrectomy referred to Loghman Hakim Hospital whom their information was available for 1 year. Patients who were consent to participate in study.
Exclusion criteria
Exclusion criteria: Female adults who were not consent to participate in study. Age < 15 years. Any adverse effect or allergy to Ursodeoxycholic Acid. Previous Cholecystectomy. Missing patient information or patient unavailability. Mental or physical diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gallstone formation. Timepoint: Weight loss data of patients will be recorded monthly. At the end of six months, abdominal ultrasound for gallstones is performed in patients and the results are analyzed. Method of measurement: Abdominal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSanaz Shishvan
Shahid Beheshti University of Medical Sciences
Outcome results
None listed